Ładuje się......

Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?

Two-thirds of breast tumours are oestrogen-receptor positive and 60–70% of these tumours respond to interventions that reduce the effects of oestrogen. Until recently, tamoxifen was the drug of choice for the treatment of hormone-responsive early and advanced breast cancer. However, tamoxifen is ass...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Sainsbury, R
Format: Artigo
Język:Inglês
Wydane: Nature Publishing Group 2004
Hasła przedmiotowe:
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2410276/
https://ncbi.nlm.nih.gov/pubmed/15150604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601731
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!